Advertisement

Journal of Applied Phycology

, Volume 27, Issue 5, pp 2075–2077 | Cite as

Are seaweed-derived fucoidans possible future anti-cancer agents?

  • Ray M. LowenthalEmail author
  • J. Helen Fitton
5th Congress of the International Society for Applied Phycology

Abstract

Is there a role for brown macroalgae-derived fucoidan in cancer therapeutics? This review discusses the in vitro, in vivo and clinical data concerning fucoidan and cancer. Fucoidans vary according to the species from which they are derived, making direct comparisons between studies difficult. Data from in vitro studies indicate direct activity against some cancer cell lines. In vivo studies indicate cancer inhibitory activity, which may also be partly attributable to increases in innate and specific immunity. A small number of preliminary clinical studies indicate activity and should be followed up. Lastly, to date, there is no reported research into potential interactions between chemotherapy and fucoidan. Other naturally derived pharmaceuticals are known to interfere with certain forms of chemotherapy, and this should not be overlooked during the development of fucoidan.

Keywords

Fucan Chemotherapy Interaction Cell lines Clinical trial 

References

  1. Ale MT, Maruyama H, Tamauchi H, Mikkelsen JD, Meyer AS (2011) Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int J Biol Macromol 49:331–336CrossRefPubMedGoogle Scholar
  2. Araya N, Takahashi K, Sato T, Nakamura T, Sawa C, Hasegawa D, Ando H, Aratani S, Yagishita N, Fujii R, Oka H, Nishioka K, Nakajima T, Mori N, Yamano Y (2011) Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir Ther 16:89–98CrossRefPubMedGoogle Scholar
  3. Bailey DG, Dresser G, Arnold JM (2013) Grapefruit-medication interactions: forbidden fruit or avoidable consequences? CMAJ 185:309–316CrossRefPubMedPubMedCentralGoogle Scholar
  4. Banafa AM, Roshan S, Liu YY, Chen HJ, Chen MJ, Yang GX, He GY (2013) Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells. J Huazhong Univ Sci Technol Med Sci 33:717–724CrossRefPubMedGoogle Scholar
  5. Berteau O, Mulloy B (2003) Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13:29R–40RCrossRefPubMedGoogle Scholar
  6. Boo HJ, Hong JY, Kim SC, Kang JI, Kim MK, Kim EJ, Hyun JW, Koh YS, Yoo ES, Kwon JM, Kang HK (2013) The anticancer effect of fucoidan in PC-3 prostate cancer cells. Mar Drugs 11:2982–2999CrossRefPubMedPubMedCentralGoogle Scholar
  7. Claudio F, Standardo B (1965) Contributo clinico sperimentale sull’uso di un fitocolloide in oncologia. Minerva Med 367:3617–3622Google Scholar
  8. Fitton JH (2011) Therapies from fucoidan; multifunctional marine polymers. Mar Drugs 9:1731–1760CrossRefPubMedPubMedCentralGoogle Scholar
  9. Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T (2008) Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol 8:109–116CrossRefPubMedGoogle Scholar
  10. Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J (2013) Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFbeta receptor degradation in breast cancer. Carcinogenesis 34:874–884CrossRefPubMedGoogle Scholar
  11. Hu Y, Cheng SC, Chan KT, Ke Y, Xue B, Sin FW, Zeng C, Xie Y (2010) Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells. Biochem Biophys Res Commun 392:329–334CrossRefPubMedGoogle Scholar
  12. Ikeguchi M, Yamamoto M, Arai Y, Maeta Y, Ashida K, Katano K, Miki Y, Kimura T (2011) Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer. Oncol Lett 2:319–322CrossRefPubMedPubMedCentralGoogle Scholar
  13. Irhimeh MR, Fitton JH, Lowenthal RM, Kongtawelert P (2005) A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find Exp Clin Pharmacol 27:705–710CrossRefPubMedGoogle Scholar
  14. Irhimeh MR, Fitton JH, Lowenthal RM (2007) Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells. Exp Hematol 35:989–994CrossRefPubMedGoogle Scholar
  15. Irhimeh MR, Fitton JH, Lowenthal RM (2009) Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul Fibrinolysis 20:607–610CrossRefPubMedGoogle Scholar
  16. Jin JO, Zhang W, Du JY, Wong KW, Oda T, Yu Q (2014) Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses. PLoS One 9:e99396CrossRefPubMedPubMedCentralGoogle Scholar
  17. Lee H, Kim JS, Kim E (2012) Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways. PLoS One 7:e50624CrossRefPubMedPubMedCentralGoogle Scholar
  18. Lee KW, Jeong D, Na K (2013) Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment. Carbohydr Polym 94:850–856CrossRefPubMedGoogle Scholar
  19. Myers SP, O’Connor J, Fitton JH, Brooks L, Rolfe M, Connellan P, Wohlmuth H, Cheras PA, Morris C (2011) A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex. Biogeosciences 5:45–60Google Scholar
  20. Negishi H, Mori M, Mori H, Yamori Y (2013) Supplementation of elderly Japanese men and women with fucoidan from seaweed increases immune responses to seasonal influenza vaccination. J Nutr 143:1794–1798CrossRefPubMedPubMedCentralGoogle Scholar
  21. Oh B, Kim J, Lu W, Rosenthal D (2014) Anticancer effect of fucoidan in combination with tyrosine kinase inhibitor lapatinib. Evid Based Complement Alternat Med 2014:865375PubMedPubMedCentralGoogle Scholar
  22. Park HS, Hwang HJ, Kim GY, Cha HJ, Kim WJ, Kim ND, Yoo YH, Choi YH (2013) Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family. Mar Drugs 11:2347–2364CrossRefPubMedPubMedCentralGoogle Scholar
  23. Park HY, Kim GY, Moon SK, Kim WJ, Yoo YH, Choi YH (2014) Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis. Molecules 19:5981–5998CrossRefPubMedGoogle Scholar
  24. Peebles KA, Baker RK, Kurz EU, Schneider BJ, Kroll DJ (2001) Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John’s wort (Hypericum perforatum). Biochem Pharmacol 62:1059–1070CrossRefPubMedGoogle Scholar
  25. Prokofjeva MM, Imbs TI, Shevchenko NM, Spirin PV, Horn S, Fehse B, Zvyagintseva TN, Prassolov VS (2013) Fucoidans as potential inhibitors of HIV-1. Mar Drugs 11:3000–3014CrossRefPubMedPubMedCentralGoogle Scholar
  26. Slichenmyer WJ, Von Hoff DD (1991) Taxol: a new and effective anti-cancer drug. Anticancer Drugs 2:519–530CrossRefPubMedGoogle Scholar
  27. Teas J, Harbison ML, Gelman RS (1984) Dietary seaweed (Laminaria) and mammary carcinogenesis in rats. Cancer Res 44:2758–2761PubMedGoogle Scholar
  28. Tokita Y, Nakajima K, Mochida H, Iha M, Nagamine T (2010) Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwich ELISA. Biosci Biotechnol Biochem 74:350–357CrossRefPubMedGoogle Scholar
  29. Ustyuzhanina NE, Ushakova NA, Zyuzina KA, Bilan MI, Elizarova AL, Somonova OV, Madzhuga AV, Krylov VB, Preobrazhenskaya ME, Usov AI, Kiselevskiy MV, Nifantiev NE (2013) Influence of fucoidans on hemostatic system. Mar Drugs 11:2444–2458CrossRefPubMedPubMedCentralGoogle Scholar
  30. Ustyuzhanina NE, Bilan MI, Ushakova NA, Usov AI, Kiselevskiy MV, Nifantiev NE (2014) Fucoidans: pro- or antiangiogenic agents? Glycobiology. doi: 10.1093/glycob/cwu063
  31. Vishchuk OS, Ermakova SP, Zvyagintseva TN (2013) The fucoidans from brown algae of Far-Eastern seas: anti-tumor activity and structure-function relationship. Food Chem 141:1211–1217CrossRefPubMedGoogle Scholar
  32. Vogelzang NJ, Raghavan D, Kennedy BJ (1982) VP-16-213 (etoposide): the mandrake root from Issyk-Kul. Am J Med 72:136–144CrossRefPubMedGoogle Scholar
  33. Whitelaw DM, Kim HS (1964) Vincristine in the treatment of neoplastic disease. Can Med Assoc J 90:1385–1389PubMedPubMedCentralGoogle Scholar
  34. Xue M, Ge Y, Zhang J, Liu Y, Wang Q, Hou L, Zheng Z (2013) Fucoidan inhibited 4 T1 mouse breast cancer cell growth in vivo and in vitro via downregulation of Wnt/beta-catenin signaling. Nutr Cancer 65:460–468CrossRefPubMedGoogle Scholar
  35. Yang L, Wang P, Wang H, Li Q, Teng H, Liu Z, Yang W, Hou L, Zou X (2013) Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar Drugs 11:1961–1976CrossRefPubMedPubMedCentralGoogle Scholar
  36. Zhang Z, Teruya K, Yoshida T, Eto H, Shirahata S (2013) Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells. Mar Drugs 11:81–98CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Menzies Research InstituteUniversity of TasmaniaHobartAustralia
  2. 2.Marinova Pty. Ltd.CambridgeAustralia

Personalised recommendations